Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Veelbelovende PET-tracer voor gebruik bij MS
dec 2017 | Multipele Sclerose